| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$532 |
Dividend/Distribution - ACL
|
26 Aug 2025 8:16AM |
$2.500 |
$2.710 |
risen by
8.40%
|
|
| Mader Group Limited (MAD) ORDINARY FULLY PAID |
Industrials |
$1,655 |
FY25 Appendix 4E
|
26 Aug 2025 8:16AM |
$8.350 |
$8.200 |
fallen by
1.80%
|
|
MAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Mader Group Limited released its FY25 Appendix 4E and annual report for the year ended 30 June 2025.
- The report outlines statutory and underlying financial results, including revenue, profit after tax, and earnings per share.
- Significant growth achieved across key geographical markets, both in Australia and internationally.
- Strategic initiatives implemented to diversify service offerings and increase operational efficiencies.
- The report discusses regulatory compliance and provides details on dividends and share capital.
- No significant changes in the company’s structure, control, or accounting policies during the reporting period.
- Commentary is provided on market conditions affecting operations, including risks and uncertainties.
- Forward-looking statements highlight the company’s focus on continued growth and shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$532 |
FY25 Results Presentation
|
26 Aug 2025 8:16AM |
$2.500 |
$2.710 |
risen by
8.40%
|
|
ACL - Price-sensitive ASX Announcement
Full Release
Key Points
- ACL reported its financial results for FY25, including revenue, EBITDA, and NPAT figures.
- The company discussed the impact of Medicare changes and regulatory shifts on its operations.
- Cost optimization measures and strategic initiatives were highlighted to address market challenges.
- ACL continues to invest in technology and business integration to drive efficiency.
- Industry challenges such as inflation and supply chain issues were acknowledged and addressed.
- The company outlined growth opportunities and focus areas for margin improvement.
- The outlook for FY25 emphasizes leveraging scale and delivering shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Motio Ltd (MXO) ORDINARY FULLY PAID |
Communication Services |
$15 |
Letter to Shareholders - Notice of Annual General Meeting
|
26 Aug 2025 8:16AM |
$0.053 |
$0.055 |
risen by
3.77%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$532 |
FY25 Results Announcement
|
26 Aug 2025 8:15AM |
$2.500 |
$2.710 |
risen by
8.40%
|
|
ACL - Price-sensitive ASX Announcement
Full Release
Key Points
- ACL reported its financial results for FY25, detailing revenue and profit figures.
- The company faced challenges from market conditions and regulatory changes impacting the pathology sector.
- ACL implemented cost management and efficiency initiatives to address rising operational costs.
- Investment in digital transformation and technology upgrades was a key strategic focus.
- The company maintained its commitment to service quality and clinical excellence.
- Dividend policy and capital management strategies were outlined in the announcement.
- ACL continues to prioritize growth opportunities and shareholder value.
- The report included an outlook on future performance and industry trends.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Motio Ltd (MXO) ORDINARY FULLY PAID |
Communication Services |
$15 |
Notice of Annual General Meeting/Proxy Form
|
26 Aug 2025 8:15AM |
$0.053 |
$0.055 |
risen by
3.77%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$532 |
Appendix 4E and Financial Report 30 June 2025
|
26 Aug 2025 8:15AM |
$2.500 |
$2.710 |
risen by
8.40%
|
|
ACL - Price-sensitive ASX Announcement
Full Release
Key Points
- Australian Clinical Labs Limited reported for the financial year ended 30 June 2025.
- Statutory revenue, profit before tax, and net profit after tax decreased compared to the prior year, primarily due to a reduction in COVID-19 testing.
- Core pathology operations remained stable, with slight growth in non-COVID-19 revenue.
- Dividend was declared and details of payment provided, reflecting ongoing shareholder returns.
- Significant investment in digital transformation, automation, and laboratory information systems to drive efficiency and innovation.
- Strategic focus on cost control, operational efficiency, and disciplined acquisition-led growth.
- Governance structure, board composition, and risk management frameworks described in detail.
- Remuneration report outlines executive performance incentives and alignment with company objectives.
- Financial statements include comprehensive notes on accounting policies, segment performance, and capital management.
- Auditor’s and directors’ declarations confirm compliance with statutory obligations and assurance of financial integrity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Felix Group Holdings Ltd (FLX) ORDINARY FULLY PAID |
Information Technology |
$42 |
Shareholder Letter - SPP
|
26 Aug 2025 8:15AM |
$0.215 |
$0.205 |
fallen by
4.65%
|
|
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$58,685 |
FY25 Full Year Results Presentation
|
26 Aug 2025 8:15AM |
$20.000 |
$19.060 |
fallen by
4.70%
|
|
FMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Fortescue delivered strong operational and financial results in FY25, maintaining disciplined cost control and high production volumes.
- Revenue and EBITDA remained robust, supporting continued shareholder returns and investment in growth projects.
- The company advanced its decarbonisation and sustainability agenda, including progress toward net zero emissions and investment in green energy technologies.
- Significant developments were made in Fortescue's green hydrogen and renewable energy initiatives through Fortescue Energy.
- Strong cash flow generation enabled further deleveraging of the balance sheet and maintained a competitive dividend payout.
- Safety performance remained a key priority, with ongoing efforts to foster a safe and inclusive workplace.
- Community engagement and social responsibility initiatives were sustained, strengthening relationships with Traditional Custodians and local stakeholders.
- The company provided updates on key growth projects and outlined a positive market outlook, reinforcing its strategic focus on resilience and value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vulcan Steel Limited (VSL) ORDINARY FULLY PAID |
Materials |
$870 |
Proposed issue of securities - VSL
|
26 Aug 2025 8:15AM |
$6.600 |
$6.600 |
fallen by
0%
|
|
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$58,685 |
FY25 Full Year Results
|
26 Aug 2025 8:15AM |
$20.000 |
$19.060 |
fallen by
4.70%
|
|
FMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Fortescue delivered a strong operational and financial performance for FY25, reporting record shipments and consistent safety outcomes.
- The company achieved total iron ore shipments of 192.2 million tonnes in FY25, maintaining its position as a leading global iron ore producer.
- Underlying EBITDA reached $11.0 billion, reflecting solid margins despite market volatility and cost pressures.
- Fortescue maintained a strong balance sheet, with net debt reduced to $1.8 billion and liquidity of $5.7 billion as of 30 June 2025.
- Sustainability and decarbonisation remain a core focus, with significant progress toward the company's target of net zero Scope 1 and 2 emissions by 2030.
- A final dividend of $1.00 per share was declared, maintaining Fortescue's commitment to shareholder returns.
- Fortescue Future Industries (FFI) advanced key green hydrogen and renewable energy projects, including final investment decisions for major developments.
- The company successfully managed inflationary and cost challenges through productivity gains and disciplined capital allocation.
- Outlook for FY26 includes continued investment in growth projects, sustained focus on safety and productivity, and advancing the green energy transition.
- Management reiterated commitment to operational excellence, capital discipline, and delivering value for shareholders and stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 29Metals Limited (29M) ORDINARY FULLY PAID |
Materials |
$439 |
Capricorn Copper TSF Application Progress Update
|
26 Aug 2025 8:15AM |
$0.285 |
$0.320 |
risen by
12.28%
|
|
29M - Price-sensitive ASX Announcement
Full Release
Key Points
- 29Metals Limited suspended operations at Capricorn Copper in March 2023 due to an extreme weather event.
- The company is seeking approval to recommence surface deposition of tailings via a new tailings storage facility, TSF4.
- A comprehensive application for the design, construction, operation, and closure of TSF4 has been submitted to the Queensland Department of Environment, Science and Innovation (DESI).
- The application is undergoing an iterative assessment process, with DESI requesting additional information and clarifications.
- 29Metals has responded to multiple rounds of information requests from the regulator.
- The company anticipates a public consultation phase as the next major step in the assessment process.
- 29Metals is committed to regulatory compliance, stakeholder engagement, and transparent communication.
- No timetable for the final decision or resumption of operations has been provided yet.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,572 |
On track for a record FY26
|
26 Aug 2025 8:14AM |
$4.600 |
$4.350 |
fallen by
5.43%
|
|
WEB - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue growth achieved during the reporting period
- Increased profitability driven by operational efficiencies
- Strong demand for travel products and services
- Strategic investments in technology and digital platforms
- Enhanced customer service contributing to positive results
- Expanded product offerings and new market entries
- Management confident of continued momentum into FY26
- Focus on digital innovation and customer experience
- Business positioned for a record fiscal year 2026
- WEB Travel Group Limited solidifies position as a leading travel company
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$58,685 |
Dividend/Distribution - FMG
|
26 Aug 2025 8:14AM |
$20.000 |
$19.060 |
fallen by
4.70%
|
|
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,572 |
AGM Managing Director's Presentation
|
26 Aug 2025 8:14AM |
$4.600 |
$4.350 |
fallen by
5.43%
|
|
WEB - Price-sensitive ASX Announcement
Full Release
Key Points
- WEB Travel Group Limited reported a net loss after tax of $1.5 million for FY2015.
- Operating revenue slightly increased, but profit margins were under pressure.
- Factors impacting performance include increased competition, investment in technology, and changing customer booking behaviors.
- The company focused on cost control and product innovation to address market challenges.
- A strategic review led to renewed emphasis on core business and rationalization of underperforming operations.
- Digital transformation and strategic partnerships are central to the growth strategy.
- Cautious optimism is expressed for future performance amid ongoing market uncertainties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$58,685 |
FY25 Annual Report and Appendix 4E
|
26 Aug 2025 8:14AM |
$20.000 |
$19.060 |
fallen by
4.70%
|
|
FMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong iron ore production and shipment volumes for FY25.
- Revenue and net profit results, with details on dividend payments.
- Continued focus on cost control and operational efficiency.
- Updates on major projects and capital expenditure.
- Progress on sustainability and decarbonisation initiatives.
- Commitment to safety and community engagement.
- Management’s discussion of market risks and strategic outlook.
- Appendix 4E financial disclosures as per ASX requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,572 |
AGM Chair's Address
|
26 Aug 2025 8:14AM |
$4.600 |
$4.350 |
fallen by
5.43%
|
|
| 29Metals Limited (29M) ORDINARY FULLY PAID |
Materials |
$439 |
2025 Half-Year Financial Results
|
26 Aug 2025 8:14AM |
$0.285 |
$0.320 |
risen by
12.28%
|
|
29M - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement of 2025 Half-Year Financial Results by 29Metals Limited.
- Details on operational and production performance for the reporting period.
- Summary of financial outcomes including revenue, cost, and profitability.
- Commentary on market conditions affecting the business.
- Overview of cost management and efficiency initiatives.
- Updates on key projects and strategic development plans.
- Discussion of safety performance and sustainability efforts.
- Engagement with local communities and stakeholders.
- Forward-looking statements regarding future performance and market expectations.
- Outline of planned activities for the remainder of the year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$58,685 |
Appendix 4G
|
26 Aug 2025 8:14AM |
$20.000 |
$19.060 |
fallen by
4.70%
|
|
| 29Metals Limited (29M) ORDINARY FULLY PAID |
Materials |
$439 |
Appendix 4D and 2025 Half-Year Financial Report
|
26 Aug 2025 8:14AM |
$0.285 |
$0.320 |
risen by
12.28%
|
|
29M - Price-sensitive ASX Announcement
Full Release
Key Points
- 29Metals Limited released its Appendix 4D and Half-Year Financial Report for the period ending 30 June 2025.
- The company reported on its financial performance, including revenue, expenses, and profit or loss for the half-year.
- The report includes detailed commentary on operational performance, including production statistics of key assets.
- Financial position and cash flows are highlighted, with attention to liquidity and funding arrangements.
- Significant events after the reporting period and their potential impacts on the company are discussed.
- A review of the economic environment and external factors affecting the business is presented.
- Dividends paid or proposed are disclosed, along with earnings per share and net tangible asset backing per share.
- The report contains statements from the Board and management, outlining strategy, risks, and future outlook.
- Audit review and signed declarations by directors are included as required under regulatory obligations.
- Compliance with Australian Securities Exchange (ASX) and corporate governance requirements is demonstrated throughout the report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NZME Limited (NZM) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$191 |
Dividend/Distribution - NZM
|
26 Aug 2025 8:14AM |
$0.990 |
$1.015 |
risen by
2.53%
|
|
| Noumi Limited (NOU) ORDINARY FULLY PAID |
Consumer Staple |
$39 |
Corporate Governance Statement
|
26 Aug 2025 8:13AM |
$0.150 |
$0.140 |
fallen by
6.67%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,578 |
Update - Notification of buy-back - DNL
|
26 Aug 2025 8:13AM |
$3.120 |
$3.060 |
fallen by
1.92%
|
|
| Holista Colltech Limited (HCT) ORDINARY FULLY PAID |
Consumer Staple |
$37 |
Binding Supply and Development Agreement with Regenerex
|
26 Aug 2025 8:13AM |
$0.088 |
$0.110 |
risen by
25%
|
|
HCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Holista Colltech Limited's subsidiary, Holista Biotech Sdn Bhd, signed a Binding Supply and Development Agreement with Regenerex Pharmaceuticals Sdn Bhd.
- The agreement concerns the Hydroxytyrosol Complex Tablet (HCT), a product with antioxidant properties.
- Regenerex will manufacture and supply HCT to Holista, which will handle distribution.
- Both companies will jointly develop and commercialize the HCT product.
- The partnership is aimed at leveraging combined resources to accelerate market entry and growth for HCT.
- The agreement is binding and forms a basis for ongoing collaboration between the two companies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Noumi Limited (NOU) ORDINARY FULLY PAID |
Consumer Staple |
$39 |
Appendix 4G
|
26 Aug 2025 8:13AM |
$0.150 |
$0.140 |
fallen by
6.67%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
